TGFB1 and neoplasm: Conversely, oncomiRs such as miR-455-3p drive chemoresistance and tumor recurrence; their silencing reduces T-IC subpopulations and simultaneously inactivates multiple stemness-associated pathways, including the Wnt/β-catenin and TGF-β/SMAD signaling pathways [167].